Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia

Purpose: Nursing home-acquired pneumonia (NHAP) patients are at higher risk of multi-drug resistant infection (MDR) than those with community-acquired pneumonia (CAP). Recent evidence suggests a single risk factor for MDR does not accurately predict the need for broad-spectrum antibiotics. The goal...

Full description

Bibliographic Details
Main Authors:	Mariana Lopes, Gonçalo Alves Silva, Rui Filipe Nogueira, Daniela Marado, João Gonçalves, Carlos Athayde, Dilva Silva, Ana Figueiredo, Jorge Fortuna, Armando Carvalho
Format:	Article
Language:	English
Published:	MDPI AG 2021-01-01
Series:	Infectious Disease Reports
Subjects:	nursing home-acquired pneumonia community-acquired pneumonia antimicrobial drug resistance epidemiology treatment failure
Online Access:	https://www.mdpi.com/2036-7449/13/1/6

Similar Items

Prognostic value of severity indicators of nursing-home-acquired pneumonia versus community-acquired pneumonia in elderly patients
by: Ugajin M, et al.
Published: (2014-02-01)

Community-acquired pneumonia /
by: Suttorp, N. (Norbert), 1953-, et al.
Published: (2007)

The Use of Inappropriate Antibiotics in Patients Admitted to Intensive Care Units with Nursing Home–Acquired Pneumonia at a Korean Teaching Hospital
by: Deok Hee Kim, M.D., et al.
Published: (2020-01-01)

Dilemma of community-acquired pneumonia
by: Lamia H Shaaban
Published: (2019-01-01)

Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)

chlamydia pneumoniae unfection in - patients with community acquired pneumonia in Iraq
by: hayfaa D. Salman
Published: (2009-01-01)

Inadequate Empirical Antibiotic Therapy in Hospital Acquired Pneumonia
by: Santosh Dahal, et al.
Published: (2015-12-01)

The COVID-19 Pandemic and the Incidence of the Non-COVID-19 Pneumonia in Adults
by: Chienhsiu Huang
Published: (2021-11-01)

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia
by: Mansoreh Momen Heravi, et al.
Published: (2023-12-01)

Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

Тhe features of severe community acquired pneumonia.
by: I. V. Avramenko
Published: (2015-06-01)

Analysis of risk factors for hospital-acquired pneumonia in schizophrenia
by: Yu-hang Chen, et al.
Published: (2024-08-01)

PES Pathogens in Severe Community-Acquired Pneumonia
by: Catia Cillóniz, et al.
Published: (2019-02-01)

Pattern of community and hospital acquired pneumonia in Egyptian military hospitals
by: Magdy Mohammad Khalil, et al.
Published: (2013-01-01)

Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia
by: Abdul-Rahman Mamdouh Mohammad, et al.
Published: (2020-12-01)

Community-acquired pneumonia
by: Milutinović-Matić Snežana R., et al.
Published: (2018-01-01)

Aerosolized antibiotics in the treatment of hospital-acquired pneumonia/ventilator-associated pneumonia
by: Yun Jung Jung, et al.
Published: (2022-01-01)

Hemogram values in community acquired pneumonia
by: Lamiaa H. Shaaban, et al.
Published: (2015-07-01)

An unusual cause of community-acquired pneumonia
by: Jaimie Mittal, et al.
Published: (2018-01-01)

Characteristics and Management of Community-Acquired Pneumonia in the Era of Global Aging
by: Catia Cillóniz, et al.
Published: (2018-04-01)

Pneumonia in nursing home patients: is it time for a specific therapeutic strategy?
by: Gualberto Gussoni, et al.
Published: (2013-04-01)

Modern characteristics of publicly acquired pneumonia caused by Clamydophyla pneumoniae
by: A. I. Danilov, et al.
Published: (2021-06-01)

Azithromycin in the Treatment of Community-acquired Pneumonia in Children
by: N. I. Zryachkin, et al.
Published: (2016-04-01)

Efficacy of immunovenin in patients with community-acquired pneumonia
by: Usman Raul'evich Farkhutdinov, et al.
Published: (2011-03-01)

Antibiotic Therapy of Mild Community-Acquired Pneumonia in Inpatients
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Community-acquired Klebsiella pneumoniae pneumonia in ICU: a multicenter retrospective study
by: Vincent Grosjean, et al.
Published: (2024-04-01)

Influence of antibiotics of different groups on the course of community-acquired pneumonia in children
by: N.Yu. Shcherbatiuk, et al.
Published: (2022-12-01)

Cytokine profile in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2022-11-01)

Community acquired paediatric pneumonia; experience from a pneumococcal vaccine- naive population
by: Sanath Thushara Kudagammana, et al.
Published: (2020-08-01)

Comprehensive risk assessment for hospital-acquired pneumonia: sociodemographic, clinical, and hospital environmental factors associated with the incidence of hospital-acquired pneumonia
by: Bo-Guen Kim, et al.
Published: (2022-01-01)

Outcomes of corticosteroid therapy in patients with viral community-acquired pneumonia
by: Catia Cilloniz, et al.
Published: (2024-09-01)

Nonlinear main components of the cytokine profile in children with community-acquired pneumonia
by: N. V. Iziurova, et al.
Published: (2024-01-01)

Characteristic Factors of Aspiration Pneumonia to Distinguish from Community-Acquired Pneumonia among Oldest-Old Patients in Primary-Care Settings of Japan
by: Toshie Manabe, et al.
Published: (2020-07-01)

Community-acquired pneumonia in HIV patients
by: I. B. Viktorova, et al.
Published: (2021-05-01)

Clarification of Systemic Corticosteroid Therapy in Community-acquired Pneumonia
by: Maryam Hassanzad, et al.
Published: (2024-06-01)

Evaluation of Comorbidities in Adult Patients with Community-Acquired Pneumonia
by: Ebru Sengul Parlak, et al.
Published: (2020-03-01)

A case of community acquired pneumonia with Pseudomonas aeruginosa
by: K Jayatilleka, et al.
Published: (2012-08-01)

Role and place of levofloxacin in the treatment of community-acquired pneumonia
by: D V Dmytriiev, et al.
Published: (2021-03-01)